Loading
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Regular session
$19.245
+$1.025 · +5.63%
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $19.245
52-week range
Current $19.245
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $19.245
52-week range
Current $19.245
Third-party consensus; not a GoAI recommendation.
Average target
$60.00
211.77% upsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM5.71M0.01%77.7B USD0.19%$279.09+0.55%
Vanguard Morningstar Total Stock Market ETFVTI1.62M0.00%2.3T USD0.03%$381.85+0.60%
iShares Russell 2000 Growth ETFIWO1.24M0.01%14.04B USD0.24%$356.96+0.99%
Schwab U.S. Small-Cap ETFSCHA1.12M0.01%21.73B USD0.03%$32.815+0.47%
iShares Russell 2000 Value ETFIWN797.18K0.01%13.75B USD0.24%$211.1+0.07%
iShares Micro-Cap ETFIWC702.42K0.05%1.32B USD0.60%$183.14+0.19%
Vanguard Extended Market ETFVXF604.75K0.00%95.4B USD0.05%$234.92+0.77%
Vanguard Russell 2000 ETFVTWO207.59K0.00%18B USD0.06%$112.73+0.56%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAiShares Russell 2000 Value ETFIWNiShares Micro-Cap ETFIWCVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
